Eyepoint Goldman Sachs June 10 2025 · page 24 of 29
The slide uses a timeline to show the transition from standard-of-care anti-VEGF injections to the DURAVYU treatment.
Consulting deck · case_study · illustrate_case · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 image 1/1 metric 1/1 title 1/1
Components 4
timeline screenshot big-number headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1